Portfolio company
Flarin
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company manufactures lipid-formulated ibuprofen capsules to treat joint and muscular pain for adult consumers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Maxwellia
This company develops and sells over-the-counter medicines for consumers, specialising in converting formerly prescription-only drugs into accessible pharmacy products.
Latigo
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.
Fortea
This company develops and sells specialised food supplements and health products to consumers seeking to manage specific medical conditions or improve general wellbeing.
Gut Wealth
This company manufactures digestive health supplements, including postbiotic capsules and liquid sachets, for individuals suffering from irritable bowel syndrome and digestive discomfort.
Cannaray
This company produces CBD oils, gummies, capsules and balms for consumers seeking wellness supplements and medical cannabis products for patients.
Flok Health
This company provides an automated physiotherapy clinic and app using artificial intelligence to deliver personalised musculoskeletal treatment for patients and healthcare providers.
Egalet
This pharmaceutical company develops and commercialises abuse-deterrent oral medicines to treat acute and chronic pain for patients and healthcare providers.
Oxford Medical Products
This company develops self-expanding hydrogel capsules to treat obesity in adults by mechanically inducing satiety and suppressing appetite.
